Published in J Pediatr Gastroenterol Nutr on October 01, 2005
Non-congenital heart disease associated pediatric pulmonary arterial hypertension. Prog Pediatr Cardiol (2009) 0.78
Hepato-portopulmonary disorders--not just in adults! J Pediatr Gastroenterol Nutr (2005) 0.75
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med (2010) 13.33
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Prevalence of fatty liver in children and adolescents. Pediatrics (2006) 7.00
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology (2012) 5.47
Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology (2005) 4.21
Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging (2008) 4.13
Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology (2009) 3.31
Heritability of nonalcoholic fatty liver disease. Gastroenterology (2009) 3.17
Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03
Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol (2007) 2.95
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology (2010) 2.86
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology (2009) 2.78
Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr (2003) 2.77
Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation (2008) 2.70
Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics (2005) 2.55
Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology (2011) 2.44
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology (2011) 2.42
Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology (2008) 2.33
Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2003) 2.23
Fatty liver: imaging patterns and pitfalls. Radiographics (2006) 2.21
Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging (2009) 2.18
Advances in pediatric nonalcoholic fatty liver disease. Hepatology (2009) 2.03
Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr (2006) 1.97
Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol (2010) 1.97
Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr (2012) 1.82
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology (2013) 1.77
Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol (2007) 1.73
Identification of EpCAM as the gene for congenital tufting enteropathy. Gastroenterology (2008) 1.65
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol (2003) 1.62
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol (2012) 1.61
Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. Gastroenterology (2013) 1.57
Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2014) 1.47
Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2015) 1.46
MMPs-2 and -14 Are Elevated in Eosinophilic Esophagitis and Reduced Following Topical Corticosteroid Therapy. J Pediatr Gastroenterol Nutr (2015) 1.43
The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects. J Pediatr (2012) 1.42
Dietary fructose in nonalcoholic fatty liver disease. Hepatology (2013) 1.39
Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder. J Clin Gastroenterol (2007) 1.29
A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. Ann Allergy Asthma Immunol (2009) 1.26
Altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients. J Pediatr Gastroenterol Nutr (2008) 1.21
Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis (2008) 1.20
Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol (2010) 1.17
Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care (2011) 1.14
Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusion. Br J Clin Pharmacol (2007) 1.12
Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trials. Clin Gastroenterol Hepatol (2008) 1.11
Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep (2008) 1.08
Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol (2013) 1.08
Fast break on the fat brake: mechanism of peroxisome proliferator-activated receptor-delta regulation of lipid accumulation in hepatocytes. Hepatology (2008) 1.08
Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol (2005) 1.07
Association between puberty and features of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2012) 1.01
Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr (2006) 1.01
Liver biopsy in modern clinical practice: a pediatric point-of-view. Adv Anat Pathol (2012) 0.98
Nonalcoholic fatty liver disease as a comorbidity of childhood obesity. Ped Health (2009) 0.96
Pediatric initiatives within the Nonalcoholic Steatohepatitis-Clinical Research Network (NASH CNR). J Pediatr Gastroenterol Nutr (2003) 0.96
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS). J Rheumatol (2009) 0.95
Hedgehog pathway and pediatric nonalcoholic fatty liver disease. Hepatology (2013) 0.95
Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease. Clin Gastroenterol Hepatol (2004) 0.95
Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery. Semin Pediatr Surg (2009) 0.95
First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future. Pediatr Nephrol (2005) 0.94
Advances in pediatric nonalcoholic fatty liver disease. Pediatr Clin North Am (2011) 0.94
Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc (2006) 0.93
Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure. Arthritis Rheum (2011) 0.92
Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg (2011) 0.91
Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2011) 0.91
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival. Chest (2008) 0.90
Clinical worsening in trials of pulmonary arterial hypertension: results and implications. Curr Opin Pulm Med (2010) 0.89
Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am J Clin Nutr (2012) 0.89
Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study. Br J Clin Pharmacol (2010) 0.89
Report of the American Gastroenterological Association (AGA) Institute Obesity Task Force. Gastroenterology (2007) 0.88
Granular cell tumor of the esophagus: report of a pediatric case and literature review. J Pediatr Gastroenterol Nutr (2004) 0.86
Exploiting phenotypic plasticity for the treatment of hepatopulmonary shunting in Abernethy malformation. J Vasc Interv Radiol (2010) 0.85
Pyruvate carboxylase deficiency--insights from liver transplantation. Mol Genet Metab (2002) 0.83
Heat shock protein-derived T-cell epitopes contribute to autoimmune inflammation in pediatric Crohn's disease. PLoS One (2009) 0.83
Drugs and the liver: advances in metabolism, toxicity, and therapeutics. Curr Opin Pediatr (2002) 0.81
Pulmonary arterial hypertension: bridging the present to the future. Eur Respir Rev (2012) 0.81
Left ventricular hemodynamic changes and clinical outcomes after transcatheter atrial septal defect closure in adults. Congenit Heart Dis (2014) 0.80
Gastrointestinal complications of mitochondrial disease. Mitochondrion (2004) 0.80
A critical appraisal of advances in pediatric nonalcoholic Fatty liver disease. Semin Liver Dis (2013) 0.80
Esophagogastric disconnection following failed fundoplication for the treatment of gastroesophageal reflux disease (GERD) in children with severe neurological impairment. Pediatr Surg Int (2004) 0.79
Estimation of fish and ω-3 fatty acid intake in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2013) 0.79
SCAI expert consensus statement for advanced training programs in pediatric and congenital interventional cardiac catheterization. Catheter Cardiovasc Interv (2014) 0.79
Hyperbaric oxygen therapy for hepatic artery thrombosis following liver transplantation: current concepts. Pediatr Transplant (2006) 0.79
Non-viral human IL-10 gene expression reduces acute rejection in heterotopic auxiliary liver transplantation in rats. Microsurgery (2003) 0.79
Domino hepatic transplantation in maple syrup urine disease. N Engl J Med (2005) 0.78
Delivery of radiofrequency ablation probes to the targeted liver malignancy: using all the players on the field. J Vasc Interv Radiol (2002) 0.77
NAFLD: The role of exercise in treating NAFLD. Nat Rev Gastroenterol Hepatol (2012) 0.77
Systems biology approach to transplant tolerance: proof of concept experiments using RNA interference (RNAi) to knock down hub genes in Jurkat and HeLa cells in vitro. J Surg Res (2011) 0.76
Medical therapy for nonalcoholic fatty liver disease in children and adolescents. Expert Rev Gastroenterol Hepatol (2012) 0.76
Polymorphisms within ASTN2 gene are associated with age at onset of Alzheimer's disease. J Neural Transm (Vienna) (2014) 0.76
Focal Fatty liver: more than just a radiographic curiosity? Gastroenterol Hepatol (N Y) (2007) 0.75
Lumen and the liver--together again in NASHville. J Pediatr Gastroenterol Nutr (2003) 0.75
Chronic constipation, atypical eating pattern, weight loss, and anxiety in a 19-year old youth. J Dev Behav Pediatr (2006) 0.75
Autologous Reconstruction and Visceral Transplantation for Management of Patients With Gut Failure After Bariatric Surgery: 20 Years of Experience. Ann Surg (2015) 0.75
Staged hybrid left pulmonary artery rehabilitation in post-fontan left pulmonary artery hypoplasia. Ann Thorac Surg (2007) 0.75
Microvascular hepatic artery reconstruction in pediatric abdominal transplantation: pearls and pitfalls. Pediatr Transplant (2007) 0.75
Chronic constipation, atypical eating pattern, weight loss, and anxiety in a 19-year old youth. J Dev Behav Pediatr (2010) 0.75
D-galactosamine based canine acute liver failure model. Hepatobiliary Pancreat Dis Int (2002) 0.75